Parathyroid hormone and bone cells

Clinical Reviews in Bone and Mineral Metabolism

Volumn 4, Issue 4, 2006, Pages 233-257

  Murrills, Richard ^a  

^a PFIZER INC   (United States)

Author keywords

Bone formation; Bone resorption; Knockout mice; Osteoblast; Osteoclast; Parathyroid hormone; RANKL

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; GROWTH FACTOR; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE RECEPTOR 2; PROSTAGLANDIN E2; PROTEIN KINASE C; TRANSCRIPTION FACTOR; WNT PROTEIN;

APOPTOSIS; BONE; BONE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; DESENSITIZATION; GAP JUNCTION; HUMAN; INTERNALIZATION; MICROARRAY ANALYSIS; MOLECULAR INTERACTION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 34147188556     PISSN: 15348644     EISSN: None     Source Type: Journal    
DOI: 10.1385/BMM:4:4:233     Document Type: Review

References (270)

1. Whitfield JF, Morley P, Willick GE. 2002 Parathyroid hormone, its fragments and their analogs for the treatment of osteoporosis. Treat Endocrinol 1:175-190.
2. Dempster DW et al. 1993 Anabolic actions of parathyroid hormone on bone. Endocr Rev 14:690-709.
3. Hock JM. 2001 Anabolic actions of PTH in the skeletons of animals. J Musculoskelet Neuronal Interact 2:33-47.
4. Bringhurst FR, Strewler GJ. 2002 Renal and skeletal actions of parathyroid hormone (PTH) and PTH-related protein. In: Bilezikian JP, Rodan GA (eds) Principles of Bone Biology. Academic, New York, pp. 483-514.
5. Juppner H et al. 1991 A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254:1024-1026.
6. Usdin TB, Bonner TI, Hoare SR. 2002 The parathyroid hormone 2 (PTH2) receptor. Receptors Channels 8:211-218.
7. Murray TM et al. 2005 Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocr Rev 26:78-113.
8. Divieti P et al. 2001 Receptors for the carboxyl-terminal region of pth(1-84) are highly expressed in osteocytic cells. Endocrinology 142:916-925.
9. Gensure RC, Gardella TJ, Juppner H. 2005 Parathyroid hormone and parathyroid hormone-related peptide, and their receptors. Biochem Biophys Res Commun 328:666-678.
10. Chorev M. 2002 Parathyroid hormone 1 receptor: insights into structure and function. Receptors Channels 8: p. 219-242.
11. Stanislaus D et al. 2000 In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment. Bone 27:209-218.
12. Lee K et al. 1994 Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids. Endocrinology 134:441-450.
13. Rouleau MF, Mitchell J, Goltzman D. 1990 Characterization of the major parathyroid hormone target cell in the endosteal metaphysis of rat long bones. J Bone Miner Res 5:1043-1053.
14. Dempster DW et al. 2005 Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts. J Cell Biochem 95:139-148.
15. Agarwala N, Gay CV. 1992 Specific binding of parathyroid hormone to living osteoclasts. J Bone Miner Res 7:531-539.
16. Seeliger S et al. 2003 The parathyroid hormone-2 receptor is expressed on human leukocytes and down-regulated in hyperparathyroidism. Clin Nephrol 59:429-435.
17. Huang JC et al. 2004 PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 19:235-244.
18. Allan EH et al. 2003 Differentiation potential of a mouse bone marrow stromal cell line. J Cell Biochem 90:158-169.
19. van der Horst G et al. 2005 Multiple Mechanisms Are Involved in Inhibition of Osteoblast Differentiation by PTHrP and PTH in KS483 Cells. J Bone Miner Res 20:2233-2244.
20. Kondo H et al. 1997 Temporal changes of mRNA expression of matrix proteins and parathyroid hormone and parathyroid hormone-related protein (PTH/PTHrP) receptor in bone development. J Bone Miner Res 12: 2089-2097.
21. Schiller PC et al. 1999 Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment. J Bone Miner Res 14:1504-1512.
22. Spurney RF. 2003 Regulated expression of G protein-coupled receptor kinases (GRK's) and beta-arrestins in osteoblasts. Calcif Tissue Int 73:153-160.
23. Calvi LM et al. 2001 Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest 107:277-286.
24. Swarthout JT et al. 2002 Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 282:1-17.
25. Singh AT et al. 2005 G alpha12/G alpha13 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells. Endocrinology 146:2171-2175.
26. Radeff JM, Nagy Z, Stern PH. 2004 Rho and Rho kinase are involved in parathyroid hormone-stimulated protein kinase C alpha translocation and IL-6 promoter activity in osteoblastic cells. J Bone Miner Res 19:1882-1891.
27. Radeff JM, Singh AT, Stern PH. 2004 Role of protein kinase A, phospholipase C and phospholipase D in parathyroid hormone receptor regulation of protein kinase C alpha and interleukin-6 in UMR-106 osteoblastic cells. Cell Signal 16:105-114.
28. Cheung R, Erclik MS, Mitchell J. 2005 1,25-dihydroxyvitamin D(3) stimulated protein kinase C phosphorylation of type VI adenylyl cyclase inhibits parathyroid hormone signal transduction in rat osteoblastic UMR 106-101 cells. J Cell Biochem 94:1017-1027.
29. Lampasso JD et al. 2002 Role of protein kinase C alpha in primary human osteoblast proliferation. J Bone Miner Res 17:1968-1976.
30. Yang D et al. 2006 Parathyroid hormone activates PKC-delta and regulates osteoblastic differentiation via a PLC-independent pathway. Bone 38:485-496.
31. Pearman AT et al. 1996 Parathyroid hormone induces c-fos promoter activity in osteoblastic cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE. J Biol Chem 271:25,715-25,721.
32. Selvamurugan N, Brown RJ, Partridge NC. 2000 Regulation of collagenase-3 gene expression in osteoblastic and non-osteoblastic cell lines. J Cell Biochem 79:182-190.
33. Selvamurugan N et al. 1998 Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence. J Biol Chem 273:10,647-10,657.
34. Selvamurugan N et al. 2000 Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alpha1. J Biol Chem 275:5037-5042.
35. Hilliker S et al. 1996 Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo. Bone 19:469-477.
36. Rixon RH et al. 1994 Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase. J Bone Miner Res 9:1179-1189.
37. Murrills RJ et al. 2004 In vitro and in vivo activities of C-terminally truncated PTH peptides reveal a disconnect between cAMP signaling and functional activity. Bone 35:1263-1272.
38. Lerner UH et al. 1989 Forskolin sensitizes parathyroid hormone-induced cyclic AMP response, but not the bone resorptive effect, in mouse calvarial bones. Bone Miner 5:169-181.
39. Bos MP et al. 1992 Role of protein kinase C (PKC) in bone resorption: effect of the specific PKC inhibitor 1-alkyl-2-methylglycerol. Biochem Biophys Res Commun 184:1317-1323.
40. Ransjo M, Lerner UH. 1990 12-O-tetradecanoylphorbol-13-acetate, a phorbol ester stimulating protein kinase C, inhibits bone resorption in vitro induced by parathyroid hormone and parathyroid hormone-related peptide of malignancy. Acta Physiol Scand 139:249-250.
41. Radeff JM, Nagy Z, Stern PH. 2001 Involvement of PKC-beta in PTH, TNF-alpha, and IL-1 beta effects on IL-6 promoter in osteoblastic cells and on PTH-stimulated bone resorption. Exp Cell Res 268:179-188.
42. Sanders JL, Stern PH. 2000 Protein kinase C involvement in interleukin-6 production by parathyroid hormone and tumor necrosis factor-alpha in UMR-106 osteoblastic cells. J Bone Miner Res 15:885-893.
43. Lee SK, Stern PH. 2000 Divergent effects of protein kinase C (PKC) inhibitors staurosporine and bisindolylmaleimide I (GF109203X) on bone resorption. Biochem Pharmacol 60:923-926.
44. Nagy Z, Radeff J, Stern PH. 2001 Stimulation of interleukin-6 promoter by parathyroid hormone, tumor necrosis factor alpha, and interleukin-1beta in UMR-106 osteoblastic cells is inhibited by protein kinase C antagonists. J Bone Miner Res 16:1220-1227.
45. Stewart PJ, Stathopoulos VM, Stern PH. 1991 Parathyroid hormone (1-34) and Nleu8,18Tyr34-parathyroid hormone, (3-34) amide increase diacylglycerol in neonatal mouse calvaria. Horm Metab Res 23:535-538.
46. Mohan S et al. 2000 Comparison of bone formation responses to parathyroid hormone(1-34), (1-31), and (2-34) in mice. Bone 27:471-478.
47. Ishizuya T et al. 1997 Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells. J Clin Invest 99:2961-2970.
48. Swarthout JT et al. 2001 Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent. J Biol Chem 276:7586-7592.
49. Fujita T et al. 2002 New signaling pathway for parathyroid hormone and cyclic AMP action on extracellularregulated kinase and cell proliferation in bone cells. Checkpoint of modulation by cyclic AMP. J Biol Chem 277:22,191-22,200.
50. Ahmed I et al. 2003 Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts. Mol Endocrinol 17:1607-1621.
51. Syme CA, Friedman PA, Bisello A. 2005 Parathyroid hormone receptor trafficking contributes to the activation of extracellular signal-regulated kinases but is not required for regulation of cAMP signaling. J Biol Chem 280:11,281-11,288.
52. Gesty-Palmer D et al. 2006 Distinct beta-arrestin and G protein dependent pathways for parathyroid hormone receptor stimulated ERK1/2 activation. J Biol Chem.
53. Xiao G et al. 2000 MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J Biol Chem 275:4453-4459.
54. Franceschi RT et al. 2003 Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation. Connect Tissue Res 44(Suppl 1):109-116.
55. Boyden LM et al. 2002 High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513-1521.
56. Little RD et al. 2002 A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70:11-19.
57. Ott SM. 2005 Sclerostin and Wnt signaling - the pathway to bone strength. J Clin Endocrinol Metab 90:6741-6743.
58. Patel MS, Karsenty G. 2002 Regulation of bone formation and vision by LRP5. N Engl J Med 346:1572-1574.
59. Babij P et al. 2003 High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18:960-974.
60. Mizuguchi T et al. 2004 LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density. J Hum Genet 49:80-86.
61. Johnson ML et al. 2004 LRP5 and Wnt signaling: a union made for bone. J Bone Miner Res 19:1749-1757.
62. Kulkarni NH et al. 2005 Effects of parathyroid hormone on Wnt signaling pathway in bone. J Cell Biochem 95:1178-1190.
63. Leman E, Bencsik M, Nguyen P, Marvi U, Nissenson RA. 2004 Synergistic actions of parathyroid hormone and beta-catenin in the canonical Wnt signaling pathway in osteoblastic cells. J Bone Miner Res 19(Suppl 1):S105.
64. Tobimatsu T, Kaji H, Sowa H, et al. 2006 Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells. Endocrinology 147:2583-90.
65. Bellido T, Ali AA, Gubrij I, et al. 2005 Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology 146:4577-83.
66. Keller H, Kneissel M. 2005 SOST is a target gene for PTH in bone. Bone 37:148-158.
67. Li X et al. 2005 Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 280:19,883-19,887.
68. van Bezooijen RL et al. 2004 Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med 199:805-814.
69. Poole KE et al. 2005 Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. Faseb J 19:1842-1844.
70. van Bezooijen RL et al. 2005 SOST/sclerostin, an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev 16:319-327.
71. Poole KE, Reeve J. 2005 Parathyroid hormone - a bone anabolic and catabolic agent. Curr Opin Pharmacol 5:612-617.
72. Kharode Y, Bodine P, Green P et al. 2004 Bone anabolic effects of PTH in LRP5 (G175V) transgenic High Bone Mass mice. J Bone Miner Res 19(Suppl 1): S105.
73. Bodine PVN, Kharode YP, Seestaller-Wehr L, Green P, Milligan C, Bex FJ. 2004 The bone anabolic effects of parathyroid hormone (PTH) are blunted by deletion of the Wnt antagonist secreted frizzled related protein (sFRP)-1. J Bone Min Res 19(Suppl 1):S17.
74. Fang X et al. 2000 Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci USA 97:11,960-11,965.
75. Chen AE, Ginty DD, Fan CM. 2005 Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins. Nature 433:317-322.
76. Spencer GJ, Utting JC, Etheridge SL, Arnett TR, Genever PG 2006 Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro. J Cell Sci 119:1283-96.
77. Hausler KD et al. 2004 Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. J Bone Miner Res 19:1873-1881.
78. Kim CH et al. 2003 Trabecular bone response to mechanical and parathyroid hormone stimulation: the role of mechanical microenvironment. J Bone Miner Res 18:2116-2125.
79. Chow JW et al. 1998 Role for parathyroid hormone in mechanical responsiveness of rat bone. Am J Physiol 274(1 Pt 1):E146-E154.
80. Tanaka S et al. 2004 Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells. J Bone Miner Res 19:1813-1820.
81. Ryder KD, Duncan RL. 2001 Parathyroid hormone enhances fluid shear-induced [Ca2+]i signaling in osteoblastic cells through activation of mechanosensitive and voltage-sensitive Ca2+ channels. J Bone Miner Res 16:240-248.
82. Li J et al. 2003 Parathyroid hormone enhances mechanically induced bone formation, possibly involving L-type voltage-sensitive calcium channels. Endocrinology 144:1226-1233.
83. Lau KH, Kapur S, Kesavan C, Baylink DJ 2006 Up-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in C57BL/6J osteoblasts as opposed to C3H/HeJ osteoblasts in part contributes to the differential anabolic response to fluid shear. J Biol Chem 281:9576-88.
84. Hens JR et al. 2005 TOPGAL mice show that the canonical Wnt signaling pathway is active during bone development and growth and is activated by mechanical loading in vitro. J Bone Miner Res 20:1103-1113.
85. Johnson ML. 2004 The high bone mass family - the role of Wnt/Lrp5 signaling in the regulation of bone mass. J Musculoskelet Neuronal Interact 4:135-138.
86. Dobnig H, Turner RT. 1995 Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3632-3638.
87. Chow JW et al. 1998 Mechanical loading stimulates bone formation by reactivation of bone lining cells in 13-week-old rats. J Bone Miner Res 13:1760-1767.
88. Sakata T et al. 2004 Skeletal unloading induces resistance to insulin-like growth factor-I (IGF-I) by inhibiting activation of the IGF-I signaling pathways. J Bone Miner Res 19:436-446.
89. Bakker AD et al. 2003 Interactive effects of PTH and mechanical stress on nitric oxide and PGE2 production by primary mouse osteoblastic cells. Am J Physiol Endocrinol Metab 285:E608-E613.
90. Komori T et al. 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
91. Ducy P et al. 1997 Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754.
92. Otto F et al. 1997 Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
93. Krishnan V et al. 2003 Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling. Mol Endocrinol 17:423-435.
94. Ducy P et al. 1999 A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 13:1025-1036.
95. Bellido T et al. 2003 Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J Biol Chem 278:50,259-50,272.
96. Ma YL et al. 2001 Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology 142:4047-4054.
97. McCauley LK et al. 2001 Parathyroid hormone stimulates fra-2 expression in osteoblastic cells in vitro and in vivo. Endocrinology 142:1975-1981.
98. Stanislaus D, Devanarayan V, Hock JM. 2000 In vivo comparison of activated protein-1 gene activation in response to human parathyroid hormone (hPTH)(1-34) and hPTH(1-84) in the distal femur metaphyses of young mice. Bone 27:819-826.
99. McCauley LK et al. 1997 Proto-oncogene c-fos is transcriptionally regulated by parathyroid hormone (PTH) and PTH-related protein in a cyclic adenosine monophosphate-dependent manner in osteoblastic cells. Endocrinology 138:5427-5433.
100. Liang JD et al. 1999 Immunohistochemical localization of selected early response genes expressed in trabecular bone of young rats given hPTH 1-34. Calcif Tissue Int 65:369-373.
101. Stein GS et al. 1996 Transcriptional control of osteoblast growth and differentiation. Physiol Rev 76:593-629.
102. Keller ET, Chang C, Ershler WB. 1996 Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone- mediated repression of the interleukin-6 promoter. J Biol Chem 271:26,267-26,275.
103. Rubin J et al. 2000 Transcriptional regulation of the expression of macrophage colony stimulating factor. Mol Cell Endocrinol 160:193-202.
104. Hess J et al. 2001 AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J Biol Chem 276:20,029-20,038.
105. Grigoriadis AE et al. 1994 c-Fos: a key regulator of osteoclast- macrophage lineage determination and bone remodeling. Science 266:443-448.
106. Demiralp B et al. 2002 Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos. Endocrinology 143:4038-4047.
107. Koh AJ, Demiralp B, Neiva KG, et al. 2005 Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone. Endocrinology 146:4584-96.
108. Martin TJ, Sims NA. 2005 Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 11:76-81.
109. Boyce BF et al. 1992 Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90:1622-1627.
110. Pirih FQ et al. 2003 Parathyroid hormone induces the nuclear orphan receptor NOR-1 in osteoblasts. Biochem Biophys Res Commun 306:144-150.
111. Pirih FQ et al. 2005 Parathyroid hormone induces the NR4A family of nuclear orphan receptors in vivo. Biochem Biophys Res Commun 332:494-503.
112. Tetradis S, Bezouglaia O, Tsingotjidou A. 2001 Parathyroid hormone induces expression of the nuclear orphan receptor Nurr1 in bone cells. Endocrinology 142:663-670.
113. Tetradis S et al. 2001 Regulation of the nuclear orphan receptor Nur77 in bone by parathyroid hormone. Biochem Biophys Res Commun 281:913-916.
114. Pirih FQ et al. 2004 Nuclear orphan receptor Nurr1 directly transactivates the osteocalcin gene in osteoblasts. J Biol Chem 279:53,167-53,174.
115. Lammi J, Huppunen J, Aarnisalo P. 2004 Regulation of the osteopontin gene by the orphan nuclear receptor NURR1 in osteoblasts. Mol Endocrinol 18:1546-1557.
116. Stains JP, Civitelli R. 2005 Gap junctions in skeletal development and function. Biochim Biophys Acta 1719:69-81.
117. Schiller PC et al. 1992 Hormonal regulation of intercellular communication: parathyroid hormone increases connexin 43 gene expression and gap-junctional communication in osteoblastic cells. Mol Endocrinol 6:1433-1440.
118. Schiller PC, Roos BA, Howard GA. 1997 Parathyroid hormone up-regulation of connexin 43 gene expression in osteoblasts depends on cell phenotype. J Bone Miner Res 12:2005-2013.
119. Civitelli R et al. 1998 Regulation of connexin43 expression and function by prostaglandin E2 (PGE2) and parathyroid hormone (PTH) in osteoblastic cells. J Cell Biochem 68:8-21.
120. Schiller PC et al. 2001 Gap-junctional communication mediates parathyroid hormone stimulation of mineralization in osteoblastic cultures. Bone 28:38-44.
121. Chung D, Civitelli R. 2005 Connexin 43 is required for a full osteoanabolic response to parathyroid hormone. J Bone Miner Res 20(Suppl 1):S58.
122. Malecz N et al. 1998 Identification of phosphorylation sites in the G protein-coupled receptor for parathyroid hormone. Receptor phosphorylation is not required for agonistinduced internalization. Mol Endocrinol 12:1846-1856.
123. Fukayama S et al. 1997 Beta-adrenergic receptor kinase-1 acutely regulates PTH/PTHrP receptor signalling in human osteoblastlike cells. Cell Signal 9:469-474.
124. Ferrari SL et al. 1999 Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves beta-arrestin2. Real-time monitoring by fluorescence microscopy. J Biol Chem 274:29,968-29,975.
125. Tawfeek HA et al. 2001 Parathyroid hormone receptor internalization is independent of protein kinase A and phospholipase C activation. Am J Physiol Endocrinol Metab 281:E545-E557.
126. Ferrari SL, Bisello A. 2001 Cellular distribution of constitutively active mutant parathyroid hormone (PTH)/PTH-related protein receptors and regulation of cyclic adenosine 3′,5′-monophosphate signaling by beta-arrestin2. Mol Endocrinol 15:149-163.
127. Chauvin S et al. 2002 Parathyroid hormone receptor recycling: role of receptor dephosphorylation and betaarrestin. Mol Endocrinol 16:2720-2732.
128. Tawfeek HA, Abou-Samra AB. 2004 Important role for the V-type H(+)-ATPase and the Golgi apparatus in the recycling of PTH/PTHrP receptor. Am J Physiol Endocrinol Metab 286:E704-E710.
129. Qin L, Raggatt LJ, Partridge NC. 2004 Parathyroid hormone: a double-edged sword for bone metabolism. Trends Endocrinol Metab 15:60-65.
130. Sneddon WB et al. 2003 Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50). J Biol Chem 278:43,787-43,796.
131. Rodan GA, Martin TJ. 1982 Role of osteoblasts in hormonal control of bone resorption - a hypothesis. Calcif Tissue Int 34:311.
132. McSheehy PM, Chambers TJ. 1986 Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 118:824-828.
133. Suda T et al. 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345-357.
134. Dougall WC et al. 1999 RANK is essential for osteoclast and lymph node development. Genes Dev 13:2412-2424.
135. Kong YY et al. 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
136. Li X et al. 2002 Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. Bone 30:567-573.
137. Iida-Klein A et al. 2002 Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. J Bone Miner Res 17:808-816.
138. Lee SK, Lorenzo JA. 1999 Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation. Endocrinology 140:3552-3561.
139. Kondo H, Guo J, Bringhurst FR. 2002 Cyclic adenosine monophosphate/ protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. J Bone Miner Res 17:1667-1679.
140. Fu Q et al. 2002 Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein. J Biol Chem 277:48,868-48,875.
141. Lee SK, Lorenzo JA. 2002 Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures. Bone 31:252-259.
142. Rogers A, Eastell R. 2005 Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 90:6323-6331.
143. Greenfield EM, Bi Y, Miyauchi A. 1999 Regulation of osteoclast activity. Life Sci 65:1087-1102.
144. Okada Y et al. 2000 Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J Clin Invest 105:823-832.
145. Liu XH et al. 2005 Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system. Endocrinology 146:1991-1998.
146. Kawaguchi H et al. 1994 Regulation of the two prostaglandin G/H synthases by parathyroid hormone, interleukin-1, cortisol, and prostaglandin E2 in cultured neonatal mouse calvariae. Endocrinology 135:1157-1164.
147. Tetradis S et al. 1997 Parathyroid hormone increases prostaglandin G/H synthase-2 transcription by a cyclic adenosine 3′,5′-monophosphate- mediated pathway in murine osteoblastic MC3T3-E1 cells. Endocrinology 138:3594-3600.
148. Pilbeam CC, Harrison JR, Raisz LG. 2002 Prostaglandins and bone metabolism. In: Bilezikian JP, Rodan GA (eds) Principles of Bone Biology. Academic, pp. 979-994.
149. Chambers TJ et al. 1985 The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology 116:234-239.
150. Kaji H et al. 1996 Prostaglandin E2 stimulates osteoclastlike cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase. J Bone Miner Res 11:62-71.
151. Take I et al. 2005 Prostaglandin E2 strongly inhibits human osteoclast formation. Endocrinology 146:5204-5214.
152. Ono K et al. 2005 Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor. J Bone Miner Res 20:23-29.
153. Li X et al. 2000 Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro. Endocrinology 141:2054-2061.
154. Greenfield EM et al. 1993 Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA. J Bone Miner Res 8:1163-1171.
155. Onyia JE et al. 1995 In vivo, human parathyroid hormone fragment (hPTH 1-34) transiently stimulates immediate early response gene expression, but not proliferation, in trabecular bone cells of young rats. Bone 17:479-484.
156. Greenfield EM et al. 1995 Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption. J Clin Invest 96:1238-1244.
157. Grey A et al. 1999 A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology 140:4683-4690.
158. Fuller K, Kirstein B, Chambers TJ 2006 Murine osteoclast formation and function: differential regulation by humoral agents. Endocrinology 147:1979-85.
159. Palmqvist P et al. 2002 IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J Immunol 169:3353-3362.
160. Kurihara N et al. 1990 IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol 144:4226-4230.
161. Kudo O et al. 2003 Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 32:1-7.
162. de la Mata J et al. 1995 Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J Clin Invest 95:2846-2852.
163. Kitamura H et al. 1995 Bone marrow neutrophilia and suppressed bone turnover in human interleukin-6 transgenic mice. A cellular relationship among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in bone marrow. Am J Pathol 147:1682-1692.
164. O'Brien CA et al. 2005 IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am J Physiol Endocrinol Metab 289:E784-E793.
165. Ragab AA et al. 2002 Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. Am J Physiol Cell Physiol 283: C679-C687.
166. Rao LG, Murray TM, Heersche JN. 1983 Immunohistochemical demonstration of parathyroid hormone binding to specific cell types in fixed rat bone tissue. Endocrinology 113:805-810.
167. Faucheux C, Horton MA, Price JS. 2002 Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone. J Bone Miner Res 17:455-464.
168. Hunter SJ, Schraer H, Gay CV. 1988 Characterization of isolated and cultured chick osteoclasts: the effects of acetazolamide, calcitonin, and parathyroid hormone on acid production. J Bone Miner Res 3:297-303.
169. May LG, Gay CV. 1997 Parathyroid hormone uses both adenylate cyclase and protein kinase C to regulate acid production in osteoclasts. J Cell Biochem 65:565-573.
170. May LG, Gay CV. 1997 Multiple G-protein involvement in parathyroid hormone regulation of acid production by osteoclasts. J Cell Biochem 64:161-170.
171. Gay CV, Weber JA. 2000 Regulation of differentiated osteoclasts. Crit Rev Eukaryot Gene Expr 10:213-230.
172. Furuyama N, Fujisawa Y. 2000 Distinct roles of cathepsin K and cathepsin L in osteoclastic bone resorption. Endocr Res 26:189-204.
173. Kakegawa H et al. 1995 Secretion and processing mechanisms of procathepsin L in bone resorption. FEBS Lett 370:78-82.
174. Kakegawa H et al. 1993 Participation of cathepsin L on bone resorption. FEBS Lett 321:247-250.
175. Aisa MC et al. 1996 Cathepsin B activity in normal human osteoblast-like cells and human osteoblastic osteosarcoma cells (MG-63): regulation by interleukin-1 beta and parathyroid hormone. Biochim Biophys Acta 1290:29-36.
176. Zhao W et al. 1999 Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. J Clin Invest 103:517-524.
177. Chambers TJ, Fuller K. 1985 Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact. J Cell Sci 76: p. 155-165.
178. Chakravarthy BR et al. 1990 Parathyroid hormone fragment [3-34] stimulates protein kinase C (PKC) activity in rat osteosarcoma and murine T-lymphoma cells. Biochem Biophys Res Commun 171:1105-1110.
179. Chakravarthy BR et al. 1990 Parathyroid hormone fragment [3-34] stimulates protein kinase C (PKC) activity in rat osteosarcoma and murine T-lymphoma cells. Biochem Biophys Res Commun 171:1105-1110.
180. Wu X, Qian W, Ryan M et al. 2005 Continuous PTH treatment causes bone loss through upregulated T cell localization to the bone surfaces. J Bone Miner Res 20(Suppl 1):S14.
181. Horwood NJ et al. 1999 Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 265:144-150.
182. Horton MA, Nesbitt SA, Bennett JH, Stenbeck G. 2002 Integrins and other cell surface attachment molecules of bone cells. In: Bilezikian JP, Rodan GA (eds) Principles of Bone Biology. Academic, New York, pp. 265-286.
183. Recker RR, Barger-Lux MJ. 2002 Transilial bone biopsy. In: Bilezikian JP, Rodan GA (eds) Principles of Bone Biology. Academic, New York, pp. 1625-1634.
184. Marks SCJ, Odgren PR. 2002 Structure and development of the skeleton. In: Bilezikian JP, Rodan GA (eds) Principles of Bone Biology. Academic, pp. 3-16.
185. Wang YH et al. 2005 Comparison of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP. J Bone Miner Res 20:5-14.
186. Bodine PV, Vernon SK, Komm BS. 1996 Establishment and hormonal regulation of a conditionally transformed preosteocytic cell line from adult human bone. Endocrinology 137:4592-4604.
187. Bodine PV et al. 1997 Functional properties of a conditionally phenotypic, estrogen-responsive, human osteoblast cell line. J Cell Biochem 65:368-387.
188. Robinson JA, Susulic V, Liu YB, et al. 2006 Identification of a PTH regulated gene selectively induced in vivo during PTH-mediated bone formation. J Cell Biochem 98:1203-20.
189. Murray TM et al. 1989 Human parathyroid hormone carboxyterminal peptide (53-84) stimulates alkaline phosphatase activity in dexamethasone-treated rat osteosarcoma cells in vitro. Endocrinology 124:1097-1099.
190. Pun KK. 1989 The importance of parathyroid hormone in inhibition of collagen synthesis and mitogenesis of osteoblastic cell. J Biochem (Tokyo) 106:1090-1093.
191. Wang A et al. 2000 Reversible suppression of in vitro bio-mineralization by activation of protein kinase A. J Biol Chem 275:11,082-11,091.
192. Bellows CG et al. 1990 Parathyroid hormone reversibly suppresses the differentiation of osteoprogenitor cells into functional osteoblasts. Endocrinology 127:3111-3116.
193. Jiang D et al. 2004 Parathyroid hormone induction of the osteocalcin gene. Requirement for an osteoblast-specific element 1 sequence in the promoter and involvement of multiple-signaling pathways. J Biol Chem 279:5329-5337.
194. Boguslawski G et al. 2000 Activation of osteocalcin transcription involves interaction of protein kinase A- and protein kinase C-dependent pathways. J Biol Chem 275:999-1006.
195. Halloran BP et al. 1997 Regional responsiveness of the tibia to intermittent administration of parathyroid hormone as affected by skeletal unloading. J Bone Miner Res 12:1068-1074.
196. Ogata Yet al. 2000 Parathyroid hormone regulation of bone sialoprotein (BSP) gene transcription is mediated through a pituitary-specific transcription factor-1 (Pit-1) motif in the rat BSP gene promoter. Matrix Biol 19:395-407.
197. Yang R, Gerstenfeld LC. 1996 Signal transduction pathways mediating parathyroid hormone stimulation of bone sialoprotein gene expression in osteoblasts. J Biol Chem 271:29,839-29,846.
198. Locklin RM et al. 2003 Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone. J Cell Biochem 89:180-190.
199. Halladay DL et al. 2001 Identification of signal transduction pathways and promoter sequences that mediate parathyroid hormone 1-38 inhibition of osteoprotegerin gene expression. J Cell Biochem 84:1-11.
200. Isogai Y et al. 1996 Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages. J Bone Miner Res 11:1384-1393.
201. Zhou H et al. 2001. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. J Bone Miner Res 16:1300-1307.
202. Sammons J et al. 2004 The role of BMP-6, IL-6, and BMP-4 in mesenchymal stem cell-dependent bone development: effects on osteoblastic differentiation induced by parathyroid hormone and vitamin D(3). Stem Cells Dev 13:273-280.
203. Hurley MM et al. 1993 Basic fibroblast growth factor inhibits type I collagen gene expression in osteoblastic MC3T3-E1 cells. J Biol Chem 268:5588-5593.
204. MacDonald BR, Gallagher JA, Russell RG. 1986 Parathyroid hormone stimulates the proliferation of cells derived from human bone. Endocrinology 118:2445-2449.
205. Lotinun S, Sibonga JD, Turner RT. 2005 Evidence that the cells responsible for marrow fibrosis in a rat model for hyperparathyroidism are preosteoblasts. Endocrinology 146:4074-4081.
206. Kostenuik PJ et al. 1999 Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I. J Bone Miner Res 14:21-31.
207. Jilka RL et al. 1999 Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439-446.
208. Chen HL et al. 2002 Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells. J Biol Chem 277:19,374-19,381.
209. Sowa H et al. 2003 Parathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblasts. J Biol Chem 278:52,240-52,252.
210. Turner PR et al. 2000 Apoptosis mediated by activation of the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein (PTHrP). Mol Endocrinol 14:241-254.
211. Conover CA, Rosen C. 2002 The role of insulin-like growth factors and binding proteins in bone cell biology. In: Bilezikian JP, Rodan GA (eds) Principles of Bone Biology. Academic, New York, pp. 801-815.
212. McCarthy TL, Centrella M, Canalis E. 1989 Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 124:1247-1253.
213. Linkhart TA, Mohan S. 1989 Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture. Endocrinology 125:1484-1491.
214. Canalis E et al. 1989 Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 83:60-65.
215. Watson P et al. 1995 Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats. Bone 16:357-365.
216. Pfeilschifter J et al. 1995 Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. J Clin Invest 96:767-774.
217. Amarnani S et al. 1993 Autocrine regulators of MC3T3-E1 cell proliferation. J Bone Miner Res 8:157-165.
218. Merriman HL et al. 1990 Insulin-like growth factor-I and insulin-like growth factor-II induce c-fos in mouse osteoblastic cells. Calcif Tissue Int 46:258-262.
219. Kaji H et al. 1997 Insulin-like growth factor-I mediates osteoclast-like cell formation stimulated by parathyroid hormone. J Cell Physiol 172:55-62.
220. Rosen CJ et al. 2005 Allelic differences in a quantitative trait locus affecting insulin-like growth factor-I impact skeletal acquisition and body composition. Pediatr Nephrol 20:255-260.
221. Miyakoshi N et al. 2001 Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. Endocrinology 142:4349-4356.
222. Bikle DD et al. 2002 Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone. J Bone Miner Res 17:1570-1578.
223. Yamaguchi M et al. 2005 Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice. Endocrinology 146:2620-2628.
224. Centrella M et al. 1994 Transforming growth factor-beta gene family members and bone. Endocr Rev 15:27-39.
225. Hattersley G, Chambers TJ. 1991 Effects of transforming growth factor beta 1 on the regulation of osteoclastic development and function. J Bone Miner Res 6:165-172.
226. Oreffo RO et al. 1989 Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. Biochem Biophys Res Commun 158:817-823.
227. Wu Y, Kumar R. 2000 Parathyroid hormone regulates transforming growth factor beta1 and beta2 synthesis in osteoblasts via divergent signaling pathways. J Bone Miner Res 15:879-884.
228. Kwok S et al. 2005 Parathyroid hormone stimulation and PKA signaling of latent transforming growth factor-beta binding protein-1 (LTBP-1) mRNA expression in osteoblastic cells. J Cell Biochem 95:1002-1011.
229. Sowa H et al. 2002 Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells. J Bone Miner Res 17:1190-1199.
230. Montero A et al. 2000 Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 105:1085-1093.
231. Hurley MM et al. 2006 Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice. Biochem Biophys Res Commun 341:989-994.
232. Hurley MM et al. 1999 Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells. J Bone Miner Res 14:776-783.
233. Hurley M, Yao W, Lane NE. 2005 Changes in serum fibroblast growth factor 2 in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34). Osteoporos Int 16:2080-2084.
234. Okada Y et al. 2003 Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone. J Biol Chem 278:21,258-21,266.
235. Pri-Chen S et al. 1998 Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture. Bone 23:111-117.
236. Canalis E, Centrella M, McCarthy T. 1988 Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest 81:1572-1577.
237. Qin L et al. 2003 Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics. J Biol Chem 278:19,723-19,731.
238. Onyia JE et al. 2005 Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarray. J Cell Biochem 95:403-418.
239. von Stechow D et al. 2004 Differential transcriptional effects of PTH and estrogen during anabolic bone formation. J Cell Biochem 93:476-490.
240. Vaes BL et al. 2002 Comprehensive microarray analysis of bone morphogenetic protein 2-induced osteoblast differentiation resulting in the identification of novel markers for bone development. J Bone Miner Res 17:2106-2118.
241. Farach-Carson MC, Xu Y. 2002 Microarray detection of gene expression changes induced by 1,25(OH)(2)D(3) and a Ca(2+) influx-activating analog in osteoblastic ROS 17/2.8 cells. Steroids 67:467-470.
242. Qin L et al. 2005 Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation. J Biol Chem 280:3974-3981.
243. Hock JM. 2000 Discrimination among osteoblasts? Parathyroid hormone analog may reveal site-specific differences in mice. Bone 27:467-469.
244. Parfitt AM. 2002 Parathyroid hormone and periosteal bone expansion. J Bone Miner Res 17:1741-1743.
245. Allen MR, Hock JM, Burr DB. 2004 Periosteum: biology, regulation, and response to osteoporosis therapies. Bone 35:1003-1012.
246. Jones DB et al. 1991 Biochemical signal transduction of mechanical strain in osteoblast-like cells. Biomaterials 12:101-110.
247. Midura RJ, Evanko SP, Hascall VC. 1994 Parathyroid hormone stimulates hyaluronan synthesis in an osteoblast-like cell line. J Biol Chem 269:13,200-13,206.
248. Mosekilde L et al. 2000 Parathyroid hormone and growth hormone have additive or synergetic effect when used as intervention treatment in ovariectomized rats with established osteopenia. Bone 26:643-651.
249. Calvi LM et al. 2004 Constitutively active PTH/PTHrP receptor in odontoblasts alters odontoblast and ameloblast function and maturation. Mech Dev 121:397-408.
250. Bouxsein ML et al. 2005 beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice. J Bone Miner Res 20:635-643.
251. Kitahara K et al. 2003 Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation. Endocrinology 144:2132-2140.
252. Reppe S et al. 2004 Butyrate response factor 1 is regulated by parathyroid hormone and bone morphogenetic protein-2 in osteoblastic cells. Biochem Biophys Res Commun 324:218-223.
253. Clohisy JC et al. 1992 Parathyroid hormone induces c-fos and c-jun messenger RNA in rat osteoblastic cells. Mol Endocrinol 6:1834-1842.
254. Ozkurt IC, Pirih FQ, Tetradis S. 2004 Parathyroid hormone induces E4bp4 messenger ribonucleic acid expression primarily through cyclic adenosine 3′,5′-monophosphate signaling in osteoblasts. Endocrinology 145:3696-3703.
255. Drake MT et al. 1994 Parathyroid hormone increases the expression of receptors for epidermal growth factor in UMR 106-101 cells. Endocrinology 134:1733-1737.
256. Nervina JM et al. 2003 Expression of inducible cAMP early repressor is coupled to the cAMP-protein kinase A signaling pathway in osteoblasts. Bone 32:483-490.
257. Erclik MS, Mitchell J. 2002 The role of protein kinase C-delta in PTH stimulation of IGF-binding protein-5 mRNA in UMR-106-101 cells. Am J Physiol Endocrinol Metab 282:E534-E541.
258. Onyia JE et al. 1997 Parathyroid hormone (1-34)-mediated interleukin-6 induction. J Cell Biochem 67:265-274.
259. Greenfield EM, Horowitz MC, Lavish SA. 1996 Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction. J Biol Chem 271:10,984-10,989.
260. Kim GS et al. 1997 Involvement of different second messengers in parathyroid hormone- and interleukin-1-induced interleukin-6 and interleukin-11 production in human bone marrow stromal cells. J Bone Miner Res 12:896-902.
261. Huang YF et al. 1998 Parathyroid hormone induces interleukin-6 heterogeneous nuclear and messenger RNA expression in murine calvarial organ cultures. Bone 23:327-332.
262. Winchester SK et al. 1999 Regulation of expression of collagenase-3 in normal, differentiating rat osteoblasts. J Cell Physiol 181:479-488.
263. Phelps E et al. 2005 Parathyroid hormone induces receptor activity modifying protein-3 (RAMP3) expression primarily via 3′,5′-cyclic adenosine monophosphate signaling in osteoblasts. Calcif Tissue Int 77:96-103.
264. Tsingotjidou A et al. 2002 Parathyroid hormone induces RGS-2 expression by a cyclic adenosine 3′,5′-monophosphate-mediated pathway in primary neonatal murine osteoblasts. Bone 30:677-684.
265. Luo XH et al. 2004 Parathyroid hormone inhibits the expression of membrane-type matrix metalloproteinase-1 (MT1-MMP) in osteoblast-like MG-63 cells. J Bone Miner Metab 22:19-25.
266. Noda M, Rodan GA. 1989 Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone. J Cell Biol 108:713-718.
267. Kawane T et al. 2003 Parathyroid hormone (PTH) down-regulates PTH/PTH-related protein receptor gene expression in UMR-106 osteoblast-like cells via a 3′,5′-cyclic adenosine monophosphate-dependent, protein kinase A-independent pathway. J Endocrinol 178:247-256.
268. Fukayama S et al. 1994 Role of protein kinase-A in homologous down-regulation of parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid in human osteoblast-like SaOS-2 cells. Endocrinology 134:1851-1858.
269. Hollnagel A, Ahrens M, Gross G. 1997 Parathyroid hormone enhances early and suppresses late stages of osteogenic and chondrogenic development in a BMP-dependent mesenchymal differentiation system (C3H10T1/2). J Bone Miner Res 12:1993-2004.
270. Kream BE et al. 1993 Parathyroid hormone represses alpha 1(I) collagen promoter activity in cultured calvariae from neonatal transgenic mice. Mol Endocrinol 7:399-408.